Roivant awards director 10,531 options, 5,054 RSUs
Roivant director Meghan Fitzgerald received stock options and RSUs that vest in 2027 as part of annual non-employee director compensation.
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) reported that director Meghan Fitzgerald received equity-based compensation on September 16, 2026. She was granted 10,531 stock options to purchase Common Shares at an exercise price of $39.57 per share, expiring on September 15, 2036, and 5,054 restricted stock units (RSUs) for Common Shares.
Both the RSUs and the stock options were granted under Roivant’s 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy and are scheduled to vest 100% on September 16, 2027, subject to her continued service as a director. After the RSU grant, she directly holds 41,162 Common Shares. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 15,585 shares
Grant/Award
2 txns
Insider
Fitzgerald Meghan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 10,531 | $0.00 | $0.00 |
| Grant/Award | Common Shares F1 | 5,054 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,531 contracts (Direct);
Common Shares — 41,162 shares (Direct)
Footnotes (2)
- F1. Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
- F2. Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
Key Figures
RSUs granted: 5,054 RSUs
Stock options granted: 10,531 options
Option exercise price: $39.57 per share
+3 more
6 metrics
RSUs granted
5,054 RSUs
Annual award of restricted stock units granted September 16, 2026
Stock options granted
10,531 options
Annual grant of stock options on September 16, 2026
Option exercise price
$39.57 per share
Exercise price for 10,531 stock options granted to director
Option expiration date
September 15, 2036
Expiration of stock options granted September 16, 2026
Vesting date for awards
September 16, 2027
Both RSUs and options vest 100% on this date, subject to service
Common Shares held after grant
41,162 shares
Direct Roivant Common Share holdings after RSU award
Key Terms
restricted stock units, stock options, 2021 Equity Incentive Plan, Non-Employee Director Compensation Policy
4 terms
restricted stock units financial
"Reflects an annual award of restricted stock units with respect to Common Shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock options financial
"Reflects an annual award of stock options to purchase Common Shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
2021 Equity Incentive Plan financial
"granted pursuant to the Company's 2021 Equity Incentive Plan"
Non-Employee Director Compensation Policy financial
"and the Company's Non-Employee Director Compensation Policy"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Roivant Sciences (ROIV) grant to director Meghan Fitzgerald?
On September 16, 2026, Meghan Fitzgerald received 10,531 stock options to purchase Roivant Common Shares at $39.57 per share, expiring September 15, 2036, and an annual award of 5,054 RSUs for Common Shares under the 2021 Equity Incentive Plan.
When do Meghan Fitzgerald’s new Roivant (ROIV) RSUs and options vest?
Roivant states that both the 5,054 RSUs and the 10,531 stock options granted to director Meghan Fitzgerald are scheduled to vest and become fully exercisable on September 16, 2027, subject generally to her continued service as a director through that date.
What is the exercise price and expiration date of Meghan Fitzgerald’s Roivant (ROIV) stock options?
The stock options granted to Meghan Fitzgerald have an exercise price of $39.57 per share and are scheduled to expire on September 15, 2036, according to Roivant’s disclosure.
Were Meghan Fitzgerald’s Roivant (ROIV) transactions under a Rule 10b5-1 trading plan?
No. Roivant’s Form 4 for Meghan Fitzgerald indicates the Rule 10b5-1 checkbox is not selected, so no Rule 10b5-1 trading plan is reported for these equity awards.
Under what plans were Meghan Fitzgerald’s Roivant (ROIV) equity awards granted?
Roivant states that the RSUs and stock options granted to Meghan Fitzgerald were issued under the company’s 2021 Equity Incentive Plan and its Non-Employee Director Compensation Policy as an annual director award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
